Display options
Cite
Sorkin GC, Dumont TM, Mokin M, et al. Hyperacute Carotid Stent Thrombosis During Emergent Revascularization Treated with Intraarterial Eptifibatide After Systemic Administration of Recombinant Tissue Plasminogen Activator. J Vasc Interv Neurol. 2015;8(3):50-5
Sorkin, G. C., Dumont, T. M., Mokin, M., Eller, J. L., Natarajan, S. K., Levy, E. I., & Siddiqui, A. H. (2015). Hyperacute Carotid Stent Thrombosis During Emergent Revascularization Treated with Intraarterial Eptifibatide After Systemic Administration of Recombinant Tissue Plasminogen Activator. Journal of vascular and interventional neurology, 8(3), 50-5.
Sorkin, Grant C, et al. "Hyperacute Carotid Stent Thrombosis During Emergent Revascularization Treated with Intraarterial Eptifibatide After Systemic Administration of Recombinant Tissue Plasminogen Activator." Journal of vascular and interventional neurology vol. 8,3 (2015): 50-5.
Sorkin GC, Dumont TM, Mokin M, Eller JL, Natarajan SK, Levy EI, Siddiqui AH. Hyperacute Carotid Stent Thrombosis During Emergent Revascularization Treated with Intraarterial Eptifibatide After Systemic Administration of Recombinant Tissue Plasminogen Activator. J Vasc Interv Neurol. 2015 Jul;8(3):50-5. PMID: 26301032; PMCID: PMC4535607.
Copy Download .nbib Format: NLM
Share it on

J Vasc Interv Neurol. 2015 Jul;8(3):50-5.

Hyperacute Carotid Stent Thrombosis During Emergent Revascularization Treated with Intraarterial Eptifibatide After Systemic Administration of Recombinant Tissue Plasminogen Activator.

Journal of vascular and interventional neurology

Grant C Sorkin, Travis M Dumont, Maxim Mokin, Jorge L Eller, Sabareesh K Natarajan, Elad I Levy, Adnan H Siddiqui

Affiliations

  1. Department of Neurosurgery, School of Medicine and Biomedical Sciences, University at Buffalo Neurosurgery, State University of New York, Buffalo, NY, USA ; Department of Neurosurgery, Gates Vascular Institute, Kaleida Health, Buffalo, NY, USA.
  2. Department of Neurosurgery, School of Medicine and Biomedical Sciences, University at Buffalo Neurosurgery, State University of New York, Buffalo, NY, USA ; Toshiba Stroke and Vascular Research Center, School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA ; Department of Radiology, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, NY, USA ; Department of Neurosurgery, Gates Vascular Institute, Kaleida Health, Buffalo, NY, USA.

PMID: 26301032 PMCID: PMC4535607

Abstract

UNLABELLED: A 57-year-old woman with National Institutes of Health Stroke Scale (NIHSS) score of 26 was found to have an acute left carotid occlusion with tandem left M1 thrombus within 1.5 hours of symptom onset. After no neurologic improvement following standard-dose intravenous (IV) recombinant tissue plasminogen activator (rtPA), emergent neuroendovascular revascularization with carotid stenting and intracranial thrombectomy were performed under conscious sedation. Thrombolysis in myocardial infarction (TIMI)-3 flow restoration and symptom resolution were achieved postprocedure; however, complete carotid stent thrombosis was noted on final angiographic runs (25 minutes later), correlating with neurologic decline. Rapid administration of an intraarterial (IA) bolus dose of eptifibatide resulted in TIMI-3 flow restoration, with neurologic improvement. The patient was discharged three days postrevascularization on dual antiplatelet therapy with an NIHSS score of 1. Intraarterial (IA) eptifibatide can be an effective option for acute stent occlusion during emergent neuroendovascular revascularization after IV rtPA administration.

ABBREVIATIONS: CLEARCombined approach to lysis utilizing eptifibatide and RtPACTcomputed tomographicFrFrenchGPglycoproteinIAintraarterialICAinternal carotid arteryIVintravenousMCAmiddle cerebral arteryNIHSSNational Institutes of Health Stroke ScalertPArecombinant tissue plasminogen activatorTIMIthrombolysis in myocardial infarction.

Keywords: carotid stent thrombosis; intraarterial eptifibatide; intravenous recombinant tissue; plasminogen activator

References

  1. AJNR Am J Neuroradiol. 2004 Sep;25(8):1411-3 - PubMed
  2. J Neurosurg. 2011 Apr;114(4):1008-13 - PubMed
  3. Stroke. 2008 Dec;39(12 ):3268-76 - PubMed
  4. Circulation. 1999 Jun 1;99(21):2720-32 - PubMed
  5. J Endovasc Ther. 2003 Oct;10(5):870-4 - PubMed
  6. Clin Cardiol. 2004 Jul;27(7):381-6 - PubMed
  7. Lancet. 2000 Dec 16;356(9247):2037-44 - PubMed
  8. J Am Coll Cardiol. 2002 Oct 2;40(7):1366-74 - PubMed
  9. Neurosurgery. 2006 Oct;59(4):789-96; discussion 796-7 - PubMed
  10. Eur Rev Med Pharmacol Sci. 2012 Mar;16(3):355-62 - PubMed
  11. Thromb Haemost. 1998 Dec;80(6):881-6 - PubMed
  12. J Vasc Surg. 2005 Nov;42(5):993-6 - PubMed
  13. Stroke. 2005 Jun;36(6):1160-5 - PubMed
  14. Drugs. 1999 Mar;57(3):439-62 - PubMed
  15. Neurosurgery. 2000 Jun;46(6):1344-59 - PubMed
  16. Am Heart J. 1998 Feb;135(2 Pt 1):268-71 - PubMed
  17. Cardiovasc Revasc Med. 2010 Apr-Jun;11(2):110-3 - PubMed
  18. Vascular. 2012 Aug;20(4):217-20 - PubMed
  19. Neuroradiology. 2005 Nov;47(11):845-54 - PubMed

Publication Types